|
Polymorphisms of Interlukin-1β rs16944 confer susceptibility to myelodysplastic syndromes
|
Nov 2016
|
Life Sci.
|
myelodysplastic syndromes (MDS)
|
|
Primary Myelodysplastic Syndromes: The Mayo Clinic Experience With 1000 Patients
|
Nov 2015
|
Mayo Clin Proc
|
myelodysplastic syndromes (MDS)
|
|
Effect of erythropoiesis-stimulating agent policy decisions on off-label use in myelodysplastic syndromes
|
Nov 2014
|
Medicare Medicaid Res Rev
|
myelodysplastic syndromes (MDS)
|
|
Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases
|
Jan 2014
|
Medicine (Baltimore)
|
|
|
Myelodysplastic Syndromes and Iron Chelation Therapy
|
Mar 2017
|
Mediterr J Hematol Infect Dis
|
myelodysplastic syndromes (MDS)
|
|
Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.
|
Feb 2017
|
Mediterr J Hematol Infect Dis
|
myelodysplastic syndromes (MDS)
|
|
Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes
|
Jan 2017
|
Methods Mol Biol
|
myelodysplastic syndromes (MDS)
|
|
Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes
|
Sep 2014
|
Mod Pathol
|
myelodysplastic syndromes (MDS)
|
|
A systematic modeling study on the pathogenic role of p38 MAPK activation in myelodysplastic syndromes
|
Feb 2012
|
Mol Biosyst
|
myelodysplastic syndromes (MDS)
|
|
Focal Adhesion Kinase as a Potential Target in AML and MDS
|
Mar 2017
|
Mol Cancer Ther
|
myelodysplastic syndromes (MDS)
|
